Erwan Guyot

1.4k total citations
20 papers, 709 citations indexed

About

Erwan Guyot is a scholar working on Epidemiology, Hepatology and Cell Biology. According to data from OpenAlex, Erwan Guyot has authored 20 papers receiving a total of 709 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 6 papers in Hepatology and 5 papers in Cell Biology. Recurrent topics in Erwan Guyot's work include Liver Disease Diagnosis and Treatment (8 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers) and Endoplasmic Reticulum Stress and Disease (3 papers). Erwan Guyot is often cited by papers focused on Liver Disease Diagnosis and Treatment (8 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers) and Endoplasmic Reticulum Stress and Disease (3 papers). Erwan Guyot collaborates with scholars based in France, Belgium and Japan. Erwan Guyot's co-authors include Aline Chevallier, Xavier Coumoul, Robert Barouki, Angéla Sutton, Pierre Nahon, Nathalie Ganne‐Carrié, Nathalie Charnaux, Christelle Laguillier, Robert Barouki and Michel Beaugrand and has published in prestigious journals such as PLoS ONE, Hepatology and Environmental Health Perspectives.

In The Last Decade

Erwan Guyot

20 papers receiving 700 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erwan Guyot France 14 275 171 148 128 90 20 709
Vijay R. More United States 14 233 0.8× 53 0.3× 88 0.6× 304 2.4× 77 0.9× 19 740
Patricia Varela Chile 16 154 0.6× 117 0.7× 45 0.3× 243 1.9× 165 1.8× 20 796
Heather B. Clair United States 13 381 1.4× 58 0.3× 221 1.5× 344 2.7× 89 1.0× 14 1.1k
Yuichi Honma Japan 11 201 0.7× 88 0.5× 56 0.4× 118 0.9× 16 0.2× 60 513
Shaohua Song China 15 147 0.5× 56 0.3× 52 0.4× 169 1.3× 25 0.3× 26 487
Hamidreza Mohammadi Iran 16 96 0.3× 114 0.7× 51 0.3× 126 1.0× 17 0.2× 35 655
Valérie Kugler France 9 251 0.9× 98 0.6× 61 0.4× 232 1.8× 45 0.5× 14 678
Déborah Vallée France 5 549 2.0× 95 0.6× 23 0.2× 270 2.1× 150 1.7× 6 817
Michèle Garlatti France 20 163 0.6× 26 0.2× 357 2.4× 436 3.4× 107 1.2× 30 1.1k
Arun P. Palanisamy United States 11 106 0.4× 74 0.4× 44 0.3× 141 1.1× 28 0.3× 24 430

Countries citing papers authored by Erwan Guyot

Since Specialization
Citations

This map shows the geographic impact of Erwan Guyot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erwan Guyot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erwan Guyot more than expected).

Fields of papers citing papers by Erwan Guyot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erwan Guyot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erwan Guyot. The network helps show where Erwan Guyot may publish in the future.

Co-authorship network of co-authors of Erwan Guyot

This figure shows the co-authorship network connecting the top 25 collaborators of Erwan Guyot. A scholar is included among the top collaborators of Erwan Guyot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erwan Guyot. Erwan Guyot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sutton, Angéla, Lorraine Blaise, Olivier Séror, et al.. (2022). Sulfatase 2 Along with Syndecan 1 and Glypican 3 Serum Levels are Associated with a Prognostic Value in Patients with Alcoholic Cirrhosis-Related Advanced Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma. Volume 9. 1369–1383. 2 indexed citations
2.
Metzinger, Laurent, Oualid Haddad, Odile Sainte‐Catherine, et al.. (2021). miR‐126‐3p is essential for CXCL12‐induced angiogenesis. Journal of Cellular and Molecular Medicine. 25(13). 6032–6045. 28 indexed citations
3.
Allaire, Manon, Erwan Guyot, G. Nkontchou, et al.. (2019). Transient elastography predicts survival after radiofrequency ablation of hepatocellular carcinoma developing on cirrhosis. Journal of Gastroenterology and Hepatology. 35(1). 142–150. 6 indexed citations
4.
Yang, Jie, Eric Trépo, Pierre Nahon, et al.. (2019). A 17‐Beta‐Hydroxysteroid Dehydrogenase 13 Variant Protects From Hepatocellular Carcinoma Development in Alcoholic Liver Disease. Hepatology. 70(1). 231–240. 84 indexed citations
5.
Trépo, Eric, Pierre Nahon, Christophe Moreno, et al.. (2019). PS-047-HSD17B13 loss of function variant protects from hepatocellular carcinoma developed on alcohol related liver disease. Journal of Hepatology. 70(1). e29–e30. 3 indexed citations
6.
Allaire, Manon, Richard Layese, Erwan Guyot, et al.. (2018). Virologic control and severity of liver disease determine survival after radiofrequency ablation of hepatocellular carcinoma on cirrhosis. Digestive and Liver Disease. 51(1). 86–94. 14 indexed citations
7.
Guyot, Erwan, Y. Ajavon, Véronique Grando, et al.. (2016). The CRP level and STATE score predict survival in cirrhotic patients with hepatocellular carcinoma treated by transarterial embolization. Digestive and Liver Disease. 48(9). 1088–1092. 14 indexed citations
8.
Saboural, Pierre, Oualid Haddad, Murielle Maire, et al.. (2016). Identification of a Pro-Angiogenic Potential and Cellular Uptake Mechanism of a LMW Highly Sulfated Fraction of Fucoidan from Ascophyllum nodosum. Marine Drugs. 14(10). 185–185. 40 indexed citations
9.
10.
Haddad, Oualid, Erwan Guyot, Fabien Chevalier, et al.. (2015). Heparanase and Syndecan-4 Are Involved in Low Molecular Weight Fucoidan-Induced Angiogenesis. Marine Drugs. 13(11). 6588–6608. 8 indexed citations
11.
12.
Juricek, Ludmila, Linh‐Chi Bui, Florent Busi, et al.. (2014). Activation of the aryl hydrocarbon receptor by carcinogenic aromatic amines and modulatory effects of their N-acetylated metabolites. Archives of Toxicology. 89(12). 2403–2412. 13 indexed citations
13.
Guyot, Erwan, Pierre Rufat, Angéla Sutton, et al.. (2014). Impact of cytokine gene variants on the prediction and prognosis of hepatocellular carcinoma in patients with cirrhosis. Journal of Hepatology. 61(2). 342–350. 20 indexed citations
14.
Saito, Naoaki, Hanna Hlawaty, V. Friand, et al.. (2014). RANTES/CCL5 mediated-biological effects depend on the syndecan-4/PKCα signaling pathway. Biology Open. 3(10). 995–1004. 10 indexed citations
15.
Nault, Jean‐Charles, Erwan Guyot, Christelle Laguillier, et al.. (2013). Serum Proteoglycans as Prognostic Biomarkers of Hepatocellular Carcinoma in Patients with Alcoholic Cirrhosis. Cancer Epidemiology Biomarkers & Prevention. 22(8). 1343–1352. 65 indexed citations
16.
Trépo, Eric, Pierre Nahon, Gianluca Bontempi, et al.. (2013). Association between the PNPLA3 (rs738409 C>G) variant and hepatocellular carcinoma: evidence from a meta-analysis of individual participant data. Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles). 24 indexed citations
17.
Kim, Min Ji, Véronique Pelloux, Erwan Guyot, et al.. (2012). Inflammatory Pathway Genes Belong to Major Targets of Persistent Organic Pollutants in Adipose Cells. Environmental Health Perspectives. 120(4). 508–514. 139 indexed citations
18.
Guyot, Erwan, Angéla Sutton, Pierre Rufat, et al.. (2012). PNPLA3 rs738409, hepatocellular carcinoma occurrence and risk model prediction in patients with cirrhosis. Journal of Hepatology. 58(2). 312–318. 104 indexed citations
19.
Guyot, Erwan, Aline Chevallier, Robert Barouki, & Xavier Coumoul. (2012). The AhR twist: ligand-dependent AhR signaling and pharmaco-toxicological implications. Drug Discovery Today. 18(9-10). 479–486. 102 indexed citations
20.
Guyot, Erwan, et al.. (2011). Identification of a new stilbene-derived inducer of paraoxonase 1 and ligand of the Aryl hydrocarbon Receptor. Biochemical Pharmacology. 83(5). 627–632. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vijay R. More Breakdown of academic impact, for papers by Patricia Varela Breakdown of academic impact, for papers by Heather B. Clair Breakdown of academic impact, for papers by Yuichi Honma Breakdown of academic impact, for papers by Shaohua Song Breakdown of academic impact, for papers by Hamidreza Mohammadi Breakdown of academic impact, for papers by Valérie Kugler Breakdown of academic impact, for papers by Déborah Vallée Breakdown of academic impact, for papers by Michèle Garlatti Breakdown of academic impact, for papers by Arun P. Palanisamy
Rankless by CCL
2026